FDA Approved First Migraine Prevention Device

Today the FDA announced their ruling on an innovative and new device that many people have been eagerly awaiting. The Cefaly is essentially a headband that can be worn to prevent migraines from developing, which would bring a significant amount of relief to the millions of people that suffer from regular migraines. The way it operates is very simple too, a self adhesive electrode sticks to the user’s forehead and sends well timed and directed electric pulses to control the onset of a migraine.

Currently the device is not available in the United States, but thanks to the FDA’s approval it will likely soon become much more available. The Cefaly is still going to remain a prescription only device, so unless your doctor says you need it you’re not going to be able to get one. The device is also only supposed to be worn for a maximum of 20 minutes per day but many doctors and researchers say that is far and beyond enough time given just how effective it is. This is absolutely great news for the millions of migraine sufferers, hopefully it’ll hit shelves soon and start making people feel a whole lot better.

This week the FDA officially approved a much anticipated diabetes drug that has been going through screening for quite some time. The drug was designed specifically as a type 2 diabetes treatment and according to the FDA it is now acceptable to sell to the public, which is absolutely great news for millions of diabetes sufferers. What makes Farxiga different from other medication is the way it works, rather than simply treating the issue, this new medication directly deals with the blood sugar generation system.

As a whole this is great news for anyone that suffers from type 2 diabetes. The drug has been proven to be successful, incredibly effective, and it is now going to be available to everyone. Doctors are very excited that Farxiga is now an approved medication and they’re likely to begin recommending it to a large number of patients in the very near future. Overall all type 2 diabetes patients are eligible to use the new drug and they might find that it is more effective and more affordable than current options, making it a big step forward. This is just another step forward in medicine that will likely be a big deal to millions of people around the world in the coming years.